Cencora, Inc.
NYSE:CORMedical - Distribution
-$5.65 today
- Market cap
- $66.47B
- Beta
- 0.59
- P/E (TTM)
- 20.7
- EPS (TTM)
- $13.10
- Dividend yield
- 0.87%
Volume 1.20M
Average 1.78M
COR Total Liabilities
Everything the company owes to creditors and other parties.
Cencora, Inc.NYSE: COR
Total Liabilities · Q3 FY2026 · quarter ended Jun 2026
Total liabilities rises 12.3% from a year ago
Total liabilities stood at $80.57B at the end of Q3 FY2026, up 12.3% from a year earlier and up 3.2% from the prior quarter. Over 3 fiscal years it compounded at +9.8% a year.
Context
- Total liabilities amounted to 96.1% of total assets at the end of Q3 FY2026, down 0.9 pp from a year earlier.
- Total liabilities increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether total liabilities keeps rising in the next quarterly balance sheet after a +12.3% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 74.84B USD
- Year-over-year change
- +12.9%
- 4-year CAGR
- +7.2%
| Period | Period end | Total Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-09-30 | 74.84B | +12.9% |
| FY2024 | 2024-09-30 | 66.31B | +7.1% |
| FY2023 | 2023-09-30 | 61.89B | +9.6% |
| FY2022 | 2022-09-30 | 56.49B | -0.5% |
| FY2021 | 2021-09-30 | 56.75B | — |
Total Liabilities vs competitors
How COR compares with its peers on the latest reported figures
- COR's Jun 2026 total liabilities of $80.57B is the 2nd highest of the 5 companies compared; the peer median is $34.53B.
- Its year-over-year change of +12.3% is the highest of 5, against a peer median of +9.3%.
- Total liabilities amounts to 96.1% of total assets for COR, versus a peer median of 104.6%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $92.19B | +12.2% | +9.2% | 104.4% | |
| Jun 2026 | $80.57B | +12.3% | +9.8% | 96.1% | |
| Sep 2026 | $62.41B | +7.7% | +9.0% | 104.8% | |
| Jun 2026 | $6.66B | +10.8% | +17.7% | 58.5% | |
| Mar 2026 | $2.88B | -32.8% | -13.1% | 119.2% | |
| Peer median (excluding COR) | $34.53B | +9.3% | +9.1% | 104.6% | |
Competitors are the stored peer set for COR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Sep 2021 | FY2022 Sep 2022 | FY2023 Sep 2023 | FY2024 Sep 2024 | FY2025 Sep 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 2.55B | 3.53B | 2.69B | 3.23B | 4.39B |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 18.39B | 18.63B | 20.91B | 23.87B | 25.23B |
| Inventory | 15.37B | 17.09B | 17.45B | 19B | 20.49B |
| Other Current Assets | 2.13B | 342.89M | 1.84B | 1.71B | 2.13B |
| Total Current Assets | 38.8B | 39.59B | 42.8B | 47.72B | 52.24B |
| Property, Plant & Equipment (Net) | 3.23B | 3.08B | 3.15B | 3.32B | 4.09B |
| Goodwill | 9.03B | 8.5B | 9.57B | 9.32B | 13.68B |
| Intangible Assets | 5.26B | 4.33B | 4.43B | 4B | 3.77B |
| Long-term Investments | 0 | 60.37M | 63.12M | 66.64M | 0 |
| Tax Assets | 290.79M | 237.57M | 200.67M | 246.35M | 208.81M |
| Other Non-current Assets | 726.81M | 756.32M | 2.34B | 2.43B | 2.6B |
| Total Non-current Assets | 18.54B | 16.97B | 19.76B | 19.38B | 24.35B |
| Total Assets | 57.34B | 56.56B | 62.56B | 67.1B | 76.59B |
| Account Payables | 38.01B | 40.19B | 45.84B | 50.94B | 54.72B |
| Short-term Debt | 475.57M | 1.23B | 823.81M | 781.1M | 371.56M |
| Tax Payables | 281.07M | 281.07M | 310.68M | 291.8M | 337.63M |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 2.87B | 2.06B | 2.17B | 2.55B | 2.73B |
| Total Current Liabilities | 41.36B | 43.48B | 48.83B | 54.28B | 57.82B |
| Long-term Debt | 7.33B | 5.5B | 5.07B | 4.84B | 8.96B |
| Deferred Tax Liabilities | 1.69B | 1.62B | 1.66B | 1.64B | 1.62B |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 5.43B | 5.03B | 5.41B | 4.52B | 5.03B |
| Total Non-current Liabilities | 15.39B | 13.01B | 13.06B | 12.04B | 17.02B |
| Total Liabilities | 56.75B | 56.49B | 61.89B | 66.31B | 74.84B |
| Common Stock | 2.91M | 2.93M | 2.95M | 2.96M | 2.97M |
| Retained Earnings | 1.67B | 2.98B | 4.32B | 5.42B | 6.53B |
| Accumulated OCI | (445.44M) | (1.83B) | (1.4B) | (989.12M) | (901.38M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 361.06M | 282.83M | 144.28M | 140.8M | 239.07M |
| Total Equity | 584.41M | 71.27M | 666.29M | 786.74M | 1.75B |
| Total Debt | 8.75B | 7.59B | 6.82B | 6.65B | 10.75B |
| Net Debt | 6.2B | 4.06B | 4.13B | 3.42B | 6.35B |
Cencora, Inc.
NYSE:COR
Intrinsic Alpha fair value
Locked
Current Price
$348.31
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.